Author:
Fernández-Gómez Paula,Pérez de la Lastra Aranda Carmen,Tosat-Bitrián Carlota,Bueso de Barrio Jesús Alejandro,Thompson Sebastián,Sot Begoña,Salas Gorka,Somoza Álvaro,Espinosa Ana,Castellanos Milagros,Palomo Valle
Abstract
The new and unique possibilities that nanomaterials offer have greatly impacted biomedicine, from the treatment and diagnosis of diseases, to the specific and optimized delivery of therapeutic agents. Technological advances in the synthesis, characterization, standardization, and therapeutic performance of nanoparticles have enabled the approval of several nanomedicines and novel applications. Discoveries continue to rise exponentially in all disease areas, from cancer to neurodegenerative diseases. In Spain, there is a substantial net of researchers involved in the development of nanodiagnostics and nanomedicines. In this review, we summarize the state of the art of nanotechnology, focusing on nanoparticles, for the treatment of diseases in Spain (2017–2022), and give a perspective on the future trends and direction that nanomedicine research is taking.
Funder
Ministerio de Ciencia e Innovación
Comunidad de Madrid
Horizon 2020 Framework Programme
“la Caixa” Foundation
Fundación Científica Asociación Española Contra el Cáncer
Ministerio de Educación y Formación Profesional
Subject
Biomedical Engineering,Histology,Bioengineering,Biotechnology